Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) has received the "Drug Registration Certificate" for the sodium alendronate oral solution approved and issued by the National Medical Products Administration.

Zhixin Finance APP news, Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) announced that recently, Shandong Xinhua Pharmaceutical Co., Ltd. has received the "Drug Registration Certificate" for the oral solution of alendronate sodium approved and issued by the National Medical Products Administration.